Sex Differences in the Efficacy of GlucagonLike Peptide1 Receptor Agonists for Weight Reduction: A Systematic Review and MetaAnalysis
(Wegovy, Mounjaro & the New Pill, 2026) Updated 22/06/26 Based on the available clinical evidence, Mounjaro (tirzepatide) and Wegovy (semaglutide) are both well tolerated, but most people find Mounjaro causes fewer gastrointestinal side effects at comparable doses, with lower rates of nausea and a higher likelihood of completing treatment
Got a fast, big headache
Yes, Lipo C vitamins are generally safe alongside GLP-1 medications since they work through separate pathways
uses "before and after" hooks and "needle-free" messaging
This superior efficacy helped it achieve global sales of ~US$16.4bn in 2024 (Mounjaro ~US$11.5bn and Zepbound ~US$4.9bn), rivalling semaglutide and completely overshadowing the sales of historical GLP-1s, such as exenatide, liraglutide and dulaglutide [FIGURE TWO]